Recent molecular design strategies for efficient photodynamic therapy and its synergistic therapy based on AIE

Jinxi Liu1, Wenting Chen1, Caiyun Zheng1

  • 1Key Laboratory of Space Bioscience and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, 710072, China.

Insights

This review explores advanced molecular design strategies for aggregation-induced emission (AIE) materials used as photosensitizers (PSs) in photodynamic therapy (PDT) for cancer treatment. It highlights methods to enhance AIE PS efficacy and enable synergistic therapies.

Area of Science:

  • Materials Science
  • Chemistry
  • Oncology

Background:

  • Cancer poses a significant threat to human health.
  • Photodynamic therapy (PDT) is a promising non-invasive cancer treatment.
  • Aggregation-induced emission (AIE) materials offer advantages over traditional photosensitizers by overcoming aggregation-caused quenching.

Purpose of the Study:

  • To review molecular design strategies for AIE-based photosensitizers (AIE PSs) in photodynamic therapy.
  • To focus on pure organic small molecule AIE PSs while also covering metal complexes and conjugated polymers.
  • To summarize design strategies for synergistic cancer therapy using AIE PSs.

Main Methods:

  • Review of literature on molecular design strategies for AIE PSs.
  • Analysis of design approaches for pure organic small molecules, metal complexes, and conjugated polymers.
  • Examination of molecular modifications for synergistic treatment applications.

Main Results:

  • Identified key molecular design strategies to enhance the photosensitization and efficacy of AIE PSs.
  • Detailed design principles for pure organic small molecule AIE PSs.
  • Summarized design approaches for metal complex and conjugated polymer AIE PSs.
  • Outlined strategies for developing functionalized AIE PSs for synergistic therapy.

Conclusions:

  • Rational molecular design is crucial for optimizing AIE PSs for effective cancer PDT.
  • Diverse design strategies exist for different types of AIE PSs, including small molecules, metal complexes, and polymers.
  • Further research into molecular modifications can unlock synergistic therapeutic approaches and address current challenges in AIE PS development.